Doris Mangiaracina Benbrook Selected Research

Doris Mangiaracina Benbrook Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2009
6	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 08/2009
4	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 03/2014
3	Carcinogenesis 03/2014 - 08/2009
2	Neoplasm Metastasis (Metastasis) 03/2022 - 08/2009
2	Inflammation (Inflammations) 03/2022 - 09/2013
1	Lymphatic Metastasis 03/2022
1	Shock 11/2021
1	Uterine Cervical Dysplasia 01/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2016
1	Adenocarcinoma 01/2016
1	Hyperplasia 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 09/2013
1	Intestinal Polyps 09/2013
1	Cardiotoxicity 09/2013
1	Polyps 09/2013
1	Carcinosarcoma 11/2012
1	Disease Progression 11/2012
1	Ovarian Epithelial Carcinoma 12/2009
1	Weight Loss (Weight Reduction) 05/2009
1	Kidney Neoplasms (Kidney Cancer) 05/2009

Drug/Important Bio-Agent (IBA)

11	(((4- nitrophenyl)amino)(2,2,4,4- tetramethyl thiochroman-6-yl)amino) methane-1-thioneIBA 01/2022 - 05/2009
6	Proteins (Proteins, Gene)FDA Link 03/2022 - 05/2009
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2009
4	mortalinIBA 01/2022 - 06/2014
3	Endoplasmic Reticulum Chaperone BiPIBA 01/2022 - 05/2021
3	Caspase 3 (Caspase-3)IBA 09/2013 - 05/2009
2	Biological ProductsIBA 11/2021 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 12/2009
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 09/2013
2	Cadherins (E-Cadherin)IBA 09/2013 - 05/2009
2	Cyclin D1IBA 09/2013 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 09/2013 - 11/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 12/2009
1	Estrogen ReceptorsIBA 03/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2022
1	Insulin ReceptorIBA 03/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2022
1	Sulfur Compounds (Compounds, Sulfur)IBA 01/2022
1	Mebendazole (Anti-Worm)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	Tamoxifen FDA LinkGeneric 01/2016
1	Progesterone FDA LinkGeneric 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	ThioureaIBA 01/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	CollagenIBA 06/2014
1	Carrier Proteins (Binding Protein)IBA 06/2014
1	Insulin (Novolin)FDA Link 03/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2013
1	Thalidomide (Thalomid)FDA Link 11/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2011
1	LigandsIBA 12/2009
1	Annexin A5IBA 12/2009
1	Death Domain ReceptorsIBA 12/2009
1	TNF-Related Apoptosis-Inducing LigandIBA 12/2009
1	Propidium (Propidium Iodide)IBA 12/2009
1	Caspase 8 (Caspase-8)IBA 12/2009
1	Glycogen Synthase (Synthase I)IBA 08/2009
1	CyclinsIBA 08/2009
1	Cell Cycle ProteinsIBA 08/2009
1	Messenger RNA (mRNA)IBA 05/2009

Therapy/Procedure

5	Therapeutics 01/2022 - 06/2011
2	Oral Administration 01/2017 - 09/2013
1	Drug Therapy (Chemotherapy) 05/2021
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2016
1	Conservative Treatment 01/2016
1	Microspheres (Microsphere) 06/2014
1	Chemoprevention 09/2013